Boost energy for maximizing performance, and Fat oxidation: converts fat into useable energy.
Again, a Phase 2 trial, recruiting patients with type 2 diabetes, randomised 281 adults to retatrutide, to a comparison drug that is already used in diabetes clinics (dulaglutide, a once-weekly drug that activates only one of retatrutide's three target receptors), or to a dummy injection (placebo) over 36 weeks
(2000) Treatment of cobalamin deficiency in dementia, evaluated clinically and with cerebral blood flow measurements
Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F